MedTrace Logo

Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia

NCT02280590 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 223

Last updated 2015-07-07

No results posted yet for this study

Summary

Comparison of the efficacy and safety of Cresnon® and Crestor® in patients with hyperlipidemia

\- 8-week, active-controlled, open-label, randomized, parallelgroup, fixed-dose, noninferiority, multicenter, phase 4 design

Conditions

Interventions

DRUG

Rosuvastatin(Cresnon®)

10mg

DRUG

Rosuvastatin(Crestor®)

10mg

Sponsors & Collaborators

  • Dong-A ST Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02280590 on ClinicalTrials.gov